Campfield Therapeutics News and Activities

Acquisition, funding and merger involving Campfield Therapeutics.

• Campfield Therapeutics has just announced a $180 Million fundraising (posted on May 25 2026).

View the org chart displaying its 4 main executives

Most searched biographies at Campfield Therapeutics

• Bill Gerhart, Chief Executive Officer
• Rita Shah, Vice President, Head of Global Regulatory Affairs
• Patricia Turney, Chief Technical Officer

Popular executive movements at Campfield Therapeutics

• Patricia Turney has joined the company as Chief Technical Officer  (posted on May 25 2026).
• Rita Shah has joined the company as Vice President, Head of Global Regulatory Affairs  (posted on May 25 2026).

Create your alert
to follow the executive moves at Campfield Therapeutics.

Campfield Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Campfield Therapeutics

Social media about Campfield Therapeutics

• Campfield Therapeutics on Wikipedia, Google News & Yahoo Finance
• Campfield Therapeutics on LinkedIn, X (Twitter) & YouTube